Molecular Methods for Rapid Identification, Antimicrobial Resistance and Management of Infections Caused by Mycobacteria
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 197
Special Issue Editor
Interests: tuberculosis; antimicrobial resistance; genomics; NGS; NTM; TB-Diagnostics; drug susceptibility testing
Special Issue Information
Dear Colleagues,
Mycobacterial infections are complex diseases and even more so in individuals suffering from immune-mediated inflammatory diseases. They can cause tuberculosis (TB), nontuberculous mycobacteria (NTM) pulmonary infections, other localized NTM or disseminated infections, leprosy, and chronic ulcers (Buruli ulcer). Rapid identification of mycobacterial infections and antimicrobial resistance detection remains one of the biggest challenges for the microbiology lab. The turnaround time for definitive identification is typically dependent on the services of an external reference lab, which may lead to long delays. Due to the increasing number of drug-resistant TB and NTM infections, the rapid differentiation of the Mycobacterium tuberculosis complex from other Mycobacteria is critical to administer appropriate treatment and establish effective public health interventions.
This Special Issue of Antibiotics will focus on the current state of knowledge on rapid identification, antimicrobial resistance and management of infections caused by Mycobacteria and on building knowledge around novel methodologies to expand the focus of genomic and drug resistance surveillance in tuberculosis and other infections caused by NTM.
Dr. Arash Ghodousi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Mycobacterium tuberculosis
- non-tuberculous mycobacteria
- mycobacteria identification
- nucleic acid amplification assays
- genome sequencing
- short & long-reads sequencing
- antimicrobial resistance surveillance
- epidemiological surveillance of tuberculosis and non-tuberculous mycobacteria
